YOUR PARTNER FOR EFFECTIVE GENE THERAPY TRIALS
Viral Vector technology is the future of Genetic Therapy today…one where more than 6,000 single-gene diseases might possibly be cured with the right gene therapies. Opportunities like this need the right partners to help those scientists on the cutting edge get their vectors manufactured, and Phase I and II trials completed.
When you trust your vector to Genezen, you’ll get some of the most experienced researchers in viral vector production and testing today, and project support to help you with the reporting, compliance and regulatory details.
To understand our offerings, click on one of the icons below: